ArticleJournal of the National Cancer Institute. Monographs2024
Global cancer stigma research: a U.S. National Cancer Institute workshop report.
Article in Journal of the National Cancer Institute. Monographs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Effectiveness of motivational interview on psychological distress of women with human papilloma virus: a randomized clinical trial.BMC women's health · 2025Trial
- Ozempic and Wegovy Meet Congress: Political Economy Without Critique and Sociology Without Society.International journal of social determinants of health and health services · 2026Article
- Perceived stigma among lung cancer patients: a cross-sectional study with latent profile analysis.BMC cancer · 2026Article
- Article
- Internalized stigma among pediatric patients with osteosarcoma and retinoblastoma in Guatemala, Jordan, and Zimbabwe.Frontiers in oncology · 2026Article
- Scoping review of psychosocial support interventions in oncology nursing: Applications across diverse and underserved cancer populations.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026Article
- Childhood cancer survivors and their caregivers are amenable to survivorship surveillance with community-based primary care providers.Journal of cancer survivorship : research and practice · 2025Article
- Cancer, HIV, and stigma: a portfolio analysis of grants funded by the National Cancer Institute.Cancer causes & control : CCC · 2025Article
- Article
- Article
- Experiences of cancer-related stigma in Africa: A scoping review.International journal of cancer · 2025Article
- "But if you don't know what my needs are, you can't help me": Health seeking experiences of older Black and Latinx cancer survivors.Journal of cancer policy · 2025Article
- Article
- Cross-cultural adaptation and psychometric validation of the breast cancer stigma assessment scale among Chinese patients.Frontiers in psychology · 2025Article
- The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer.Molecules (Basel, Switzerland) · 2024Article
- The global landscape of cancer stigma research and practice: perspectives, measures, interventions, and actions for change.Journal of the National Cancer Institute. Monographs · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Stigma is a social process characterized by negative beliefs, attitudes, and stereotypes associated with a specific attribute or characteristic that leads to discrimination and social exclusion. Stigma manifests across the cancer control continuum and remains a key challenge for cancer prevention and control worldwide. In this commentary, we provide an overview of the U.S. National Cancer Institute's (NCI) Global Cancer Stigma Research Workshop, a multi-disciplinary international conference held virtually in September 2022, which focused on the intersection of cancer and stigma. The meeting was unique in its convening of researchers, advocates, clinicians, and non-governmental and governmental organizations, who-as a collective-provided overarching topics, cross-cutting considerations, and future directions for the cancer stigma research community to consider, which we describe herein. In summary, studying cancer stigma comprehensively requires a holistic, adaptive, and multifaceted approach-and should consider interrelated factors and their intersection within diverse cultural and social contexts worldwide. Collectively, there was a call for: an inclusive approach, encouraging researchers and practitioners to identify and measure cancer stigma as a driver for cancer health inequities globally; an expansion of existing research methodology to include diversity of experiences, contexts, and perspectives; and collaborations among diverse stakeholders to develop more effective strategies for reducing stigma and improving cancer outcomes. Such efforts are essential to cultivating effective and equitable approaches to preventing and treating cancer worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.